OLANZAPINE injection, powder, lyophilized, for solution [GLENMARK PHARMACEUTICALS INC., USA]

10 Apr 20264 min read0 viewsVerified Feed

GIST

Updated Date: Fri, 10 Apr 2026 00:00:00 EDT

Clinical Editorial

Summary

DailyMed Drug Label Updates published a clinical update in Pharmacology on 10 Apr 2026. The item focuses on OLANZAPINE injection, powder, lyophilized, for solution [GLENMARK PHARMACEUTICALS INC., USA]. Open the detail page to review the full original feed content.

Source Reference

Read the full original publication from the source journal or publisher link below.

Open Original Source More Feed Items

Related by Condition/Drug

BMJRelated by Specialty

BUPROPION HYDROCHLORIDE XL (bupropion hydrochloride) tablet, extended release [Lupin Pharmaceuticals, Inc.]

Pharmacology • 23 Apr 2026

DailyMedRelated by Specialty

BUPROPION HYDROCHLORIDE SR (bupropion hydrochloride) tablet, film coated, extended release [Cardinal Health 107, LLC]

Pharmacology • 23 Apr 2026

Feed Metadata

Source

DailyMed Drug Label Updates